EX-99.1 2 d924910dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

The following amendment has been made to the Result of Annual General Meeting (‘AGM’) announcement released on May 8, 2025 at 14:00 under RNS Number 9352H.

The number of votes against resolution 6. To elect Dr. David Wheadon, has been updated to 14,624,894.

All other details remain unchanged.

The full amended text is shown below.

Indivior PLC (the ‘Company’)

Result of Annual General Meeting (‘AGM’)

May 8, 2025

The Company announces the voting results of its AGM, held earlier today at the Marlborough Theatre, No. 11 Cavendish Square, London, W1G 0AN. All resolutions were duly passed by shareholders by way of a poll.

Details of each resolution are set out in the Notice of Meeting circulated to shareholders on March 27, 2025. The voting results, incorporating proxy votes lodged in advance of the AGM, are set out below and will be made available on the Company’s website at http://www.indivior.com/en/investors/shareholder-information.

 

RESOLUTION

   VOTES
FOR
     %     VOTES
AGAINST
     %     VOTES
TOTAL
     % of ISC
VOTED1
    VOTES
WITHHELD2
 
1. To receive the Annual Report and Accounts      79,773,958        100.00     2,502        0.00     79,776,460        63.94     227,842  
2. To approve the Directors’ Remuneration Report      76,166,363        95.31     3,747,204        4.69     79,913,567        64.05     90,735  
3. To approve the Directors’ Remuneration Policy      74,447,950        93.16     5,464,988        6.84     79,912,938        64.05     91,364  
4. To elect Joseph Ciaffoni      79,725,151        99.72     225,142        0.28     79,950,293        64.08     54,009  
5. To elect Daniel Ninivaggi      78,875,142        98.66     1,073,927        1.34     79,949,069        64.08     55,232  
6. To elect Dr. David Wheadon      65,324,886        81.71     14,624,894        18.29     79,949,780        64.08     54,521  
7. To re-elect Dr. Keith Humphreys      71,220,343        89.08     8,732,129        10.92     79,952,472        64.08     51,830  
8. To re-elect Barbara Ryan      66,278,304        82.93     13,645,584        17.07     79,923,888        64.06     80,414  
9. To re-elect Mark Stejbach      66,449,177        83.11     13,503,305        16.89     79,952,482        64.08     51,820  
10. To re-elect Juliet Thompson      65,523,796        81.98     14,399,386        18.02     79,923,182        64.06     81,120  


11. To re-appoint PricewaterhouseCoopers LLP as Auditor      79,077,334        98.90     880,211        1.10     79,957,545        64.08     46,757  
12. To authorize the Audit & Risk Committee to determine the remuneration of the Auditor      79,820,100        99.83     138,138        0.17     79,958,238        64.08     46,064  
13. To authorize the Company and any of its UK subsidiaries to make political donations and incur political expenditure      78,832,165        98.79     964,328        1.21     79,796,493        63.96     207,808  
14. To authorize the Directors to allot shares      79,153,182        99.09     723,748        0.91     79,876,930        64.02     127,372  
15. To authorize the Directors to disapply pre-emption rights up to 10% of the issued capital (Special Resolution)      78,961,024        98.82     941,908        1.18     79,902,932        64.04     101,370  
16. To authorize the Directors to disapply pre-emption rights up to an additional 10% for transactions which the Board determines to be an acquisition or other capital investment (Special Resolution)      78,287,338        98.02     1,584,404        1.98     79,871,742        64.02     132,559  
17. To authorize market purchases of the Company’s ordinary shares (Special Resolution)      79,831,447        99.94     48,147        0.06     79,879,594        64.02     124,708  
18. To call a general meeting other than an annual general meeting on not less than 14 clear days’ notice (Special Resolution)      78,847,776        98.60     1,119,509        1.40     79,967,285        64.09     37,017  
19. To adopt the new Articles of Association (Special Resolution)      79,666,957        99.64     290,995        0.36     79,957,952        64.08     46,350  

Notes:

 

1.

As at the close of business on May 8, 2024, the total number of ordinary shares of US$0.50 eligible to be voted at the AGM was 124,769,533. Therefore, the total voting rights in the Company as at that time was 124,769,533.

2.

A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.


A copy of the special business resolutions will be submitted to the National Storage Mechanism and will be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism in due course.

Computershare Investor Services PLC acted as scrutineer of the poll on all resolutions.

Key Contacts:

Jason Thompson

VP, Investor Relations

+1 804-402-7123 or jason.thompson@indivior.com

Tim Owens

Director, Investor Relations

+1 804-263-3978 or timothy.owens@indivior.com

Alice Givens

Company Secretary

+1 804-659-7741 or alice.givens@Indivior.com

About Indivior

Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of OUD. Indivior is dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

Indivior PLC’s Legal Entity Identifier code is 213800V3NCQTY7IED471.